RAP functions in ER maturation of lipoprotein receptor family members by acting as an antagonist. It blocks binding of PCSK9 to lipoprotein receptors and of all known ligands (including MMP-9 and apoE) to lipoprotein receptor-related protein 1 (LRP-1). Modulates amyloid deposition in mouse models of Alzheimer’s disease. Reduces endocytosis of prion protein (PrPc) by neuronal cells.
Product Specification
| MW: | ~39kDa (SDS-PAGE) |
| |
| Purity: | ≥90% (SDS-PAGE) |
| |
| Source/Host: | Produced in E. coli. |
| |
| Application: | Binding studies, and testing in vivo and in cell culture. |
| |
| Shipping: | SHIPPED ON DRY ICE |
| |
| Long Term Storage: | -80°C |
| |
| Handling: | After opening, prepare aliquots and store at -80°C. Avoid freeze/thaw cycles. |
| |
| Background / Technical Information: | Please click here for the comprehensive product data sheet. |
| |